Outcomes and resource utilization in surgery for Chiari I malformation in a national network of children’s hospitals

2018 ◽  
Vol 35 (4) ◽  
pp. 657-664 ◽  
Author(s):  
Melissa A. LoPresti ◽  
I-Wen Pan ◽  
Nisha Gadgil ◽  
Kathryn Wagner ◽  
Sandi Lam
2019 ◽  
Vol 38 (9) ◽  
pp. 977-978 ◽  
Author(s):  
Gabrielle Z. Hester ◽  
Amanda J. Nickel ◽  
Patricia A. Stinchfield ◽  
Alicen B. Spaulding

2016 ◽  
Vol 20 (7) ◽  
pp. 921-925 ◽  
Author(s):  
Jennifer A. Minneman ◽  
James L. Grijalva ◽  
Michael J. LaQuaglia ◽  
Heung Bae Kim ◽  
Shawn J. Rangel ◽  
...  

2016 ◽  
Vol 11 (5) ◽  
pp. 317-323 ◽  
Author(s):  
Kavita Parikh ◽  
Matt Hall ◽  
Anne J. Blaschke ◽  
Carlos G. Grijalva ◽  
Thomas V. Brogan ◽  
...  

Neurosurgery ◽  
2013 ◽  
Vol 72 (6) ◽  
pp. 922-929 ◽  
Author(s):  
Zachary N. Litvack ◽  
Rebecca A. Lindsay ◽  
Nathan R. Selden

Abstract BACKGROUND: Dural splitting decompression may be an effective and safe treatment for Chiari I malformation. OBJECTIVE: To compare clinical outcomes, complications, and resource utilization for patients undergoing Chiari I decompression with or without duraplasty. METHODS: Between 2000 and 2009, the senior author performed 113 Chiari I decompression operations with dural splitting or duraplasty in children less than 18 years of age; 110 were included in a retrospective cohort analysis of safety, efficacy, and treatment cost. Patients without significant syringomyelia underwent dural splitting decompression, and patients with syringomyelia underwent duraplasty. RESULTS: Sixty-three patients without significant syringomyelia (57%) underwent dural splitting decompression. They were significantly younger than patients undergoing duraplasty (8.3 ± 4.9 years vs 10.4 ± 4.4 years; P < .05). Headaches improved or resolved in most patients in both groups (90.5% vs 93.6%; P = .59). Dysphagia, long tract signs, cranial nerve, and bulbar symptoms also improved similarly in both groups. Three duraplasty patients were treated medically for aseptic meningitis; one underwent reoperation for a symptomatic pseudomeningocele. No patient undergoing dural splitting decompression experienced a cerebrospinal fluid-related complication. Extradural decompression required less operative time than duraplasty (105.5 vs 168.9 minutes, P < .001), a shorter length of stay (2.4 vs 2.8 days, P = .011), and lower total cost for the primary hospitalization ($26 837 vs $29 862, P = .015). CONCLUSION: In this retrospective cohort study, dural splitting decompression was equally effective, safer, and lower cost for treatment of Chiari I malformation without syringomyelia. A multicenter trial with groups balanced for the presence of syringomyelia is necessary to determine whether these results are generalizable.


PEDIATRICS ◽  
2013 ◽  
Vol 131 (6) ◽  
pp. 1050-1058 ◽  
Author(s):  
E. S. Fieldston ◽  
S. S. Shah ◽  
M. Hall ◽  
P. D. Hain ◽  
E. R. Alpern ◽  
...  

2020 ◽  
Vol 41 (5) ◽  
pp. 571-578
Author(s):  
Hannah G. Griffith ◽  
Keerti Dantuluri ◽  
Cary Thurm ◽  
Derek J. Williams ◽  
Ritu Banerjee ◽  
...  

AbstractObjective:To characterize the prevalence of and seasonal and regional variation in inpatient antibiotic use among hospitalized US children in 2017–2018.Design:We conducted a cross-sectional examination of hospitalized children. The assessments were conducted on a single day in spring (May 3, 2017), summer (August 2, 2017), fall (October 25, 2017), and winter (January 31, 2018). The main outcome of interest was receipt of an antibiotic on the study day.Setting:The study included 51 freestanding US children’s hospitals that participate in the Pediatric Health Information System (PHIS).Patients:This study included all patients <18 years old who were admitted to a participating PHIS hospital, excluding patients who were admitted solely for research purposes.Results:Of 52,769 total hospitalized children, 19,174 (36.3%) received antibiotics on the study day and 6,575 of these (12.5%) received broad-spectrum antibiotics. The overall prevalence of antibiotic use varied across hospitals from 22.3% to 51.9%. Antibiotic use prevalence was 29.2% among medical patients and 47.7% among surgical patients. Although there was no significant seasonal variation in antibiotic use prevalence, regional prevalence varied, ranging from 32.7% in the Midwest to 40.2% in the West (P < .001). Among units, pediatric intensive care unit patients had the highest prevalence of both overall and broad-spectrum antibiotic use at 58.3% and 26.6%, respectively (P < .001).Conclusions:On any given day in a national network of children’s hospitals, more than one-third of hospitalized children received an antibiotic, and 1 in 8 received a broad-spectrum antibiotic. Variation across hospitals, setting and regions identifies potential opportunities for enhanced antibiotic stewardship activities.


Sign in / Sign up

Export Citation Format

Share Document